L'Heureux R, Dennis T, Curet O, Scatton B
J Neurochem. 1986 Jun;46(6):1794-801. doi: 10.1111/j.1471-4159.1986.tb08498.x.
The release of endogenous noradrenaline was measured in the cerebral cortex of the halothane-anesthetized rat by using the technique of brain dialysis coupled to a radioenzymatic assay. A thin dialysis tube was inserted transversally in the cerebral cortex (transcortical dialysis) and perfused with Ringer medium (2 microliter min-1). Under basal conditions, the cortical output of noradrenaline was stable over a period of at least 6 h and amounted to 8.7 pg/20 min (not corrected for recovery). Histological control of the perfused area revealed very little damage and normal morphology in the vicinity of the dialysis tube. Omission of calcium from the perfusion medium caused a marked drop in cortical noradrenaline output. Bilateral electrical stimulation (for 10 min) of the ascending noradrenergic pathways in the medial forebrain bundle caused a frequency-dependent increase in cortical noradrenaline output over the range 5-20 Hz. Stimulation at a higher frequency (50 Hz) resulted in a levelling off of the increase in cortical noradrenaline release. Systemic administration of the dopamine-beta-hydroxylase inhibitor bis-(4-methyl-1-homopiperazinylthiocarbonyl) disulfide (FLA 63) (25 mg/kg i.p.) markedly reduced, whereas injection of the monoamine oxidase inhibitor pargyline (75 mg/kg i.p.) resulted in a progressive increase in, cortical noradrenaline output. d-Amphetamine (2 mg/kg i.p.) provoked a sharp increase in cortical noradrenaline release (+450% over basal values within 40 min). Desmethylimipramine (10 mg/kg i.p.) produced a twofold increase of cortical noradrenaline release. Finally, idazoxan (20 mg/kg i.p.) and clonidine (0.3 mg/kg i.p.), respectively, increased and decreased the release of noradrenaline from the cerebral cortex.(ABSTRACT TRUNCATED AT 250 WORDS)
采用脑透析技术结合放射酶分析法,测定了氟烷麻醉大鼠大脑皮层内源性去甲肾上腺素的释放量。将一根细透析管横向插入大脑皮层(经皮层透析),并用林格氏液(2微升/分钟)进行灌注。在基础条件下,去甲肾上腺素的皮层输出在至少6小时内保持稳定,为8.7皮克/20分钟(未校正回收率)。对灌注区域的组织学检查显示,透析管附近损伤极小,形态正常。灌注液中去除钙会导致皮层去甲肾上腺素输出显著下降。对内侧前脑束中去甲肾上腺素能上行通路进行双侧电刺激(10分钟),在5 - 20赫兹范围内,皮层去甲肾上腺素输出随频率增加而升高。更高频率(50赫兹)刺激导致皮层去甲肾上腺素释放增加趋于平稳。全身注射多巴胺-β-羟化酶抑制剂双-(4-甲基-1-高哌嗪基硫代羰基)二硫化物(FLA 63)(25毫克/千克,腹腔注射)显著降低了皮层去甲肾上腺素输出,而注射单胺氧化酶抑制剂优降宁(75毫克/千克,腹腔注射)则导致皮层去甲肾上腺素输出逐渐增加。右旋苯丙胺(2毫克/千克,腹腔注射)使皮层去甲肾上腺素释放急剧增加(40分钟内比基础值增加450%)。去甲替林(10毫克/千克,腹腔注射)使皮层去甲肾上腺素释放增加两倍。最后,咪唑克生(20毫克/千克,腹腔注射)和可乐定(0.3毫克/千克,腹腔注射)分别增加和减少了大脑皮层去甲肾上腺素的释放。(摘要截取自250字)